Achillion Pharmaceuticals, Inc. (Nasdaq: ACHN) announced that Joel Barrish, Ph.D., has been named the Company’s Chief Scientific Officer (CSO) and ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE